Moderna announces dosing of first monoclonal antibody encoded by mRNA in clinical trial

Moderna has announced the dosing of the first subject in a phase 1 clinical trial evaluating the safety and tolerability of escalating doses of mRNA-1944 via intravenous infusion in healthy adults.